Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Aftertreated polymer
Patent
1993-06-15
1995-10-24
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Aftertreated polymer
424 7811, 424 7814, 424 7808, 514824, 514825, 514619, 514626, A61K 31785, A61K 31795, C08G 7102
Patent
active
054608074
ABSTRACT:
The oligomers of the present invention are polyureas or polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone with a predictable anion spacing, and are pharmaceutically-acceptable. The oligomers are useful for inhibiting the proliferation of smooth muscle cell.
REFERENCES:
patent: 2833744 (1958-05-01), Neher
patent: 3528949 (1970-09-01), Rutledge
patent: 3993625 (1976-11-01), Kurihara et al.
patent: 4073768 (1978-02-01), Mark
patent: 4104262 (1978-08-01), Schade
patent: 4312855 (1982-01-01), Grand
patent: 4471110 (1984-09-01), Christell
patent: 4604404 (1986-08-01), Munson
patent: 4736014 (1988-04-01), Engelhardt et al.
patent: 4756907 (1988-07-01), Beck et al.
patent: 4824916 (1989-04-01), Kershner et al.
patent: 4863735 (1989-09-01), Kohn et al.
patent: 4895660 (1990-01-01), Kershner et al.
patent: 4897260 (1990-01-01), Ross et al.
patent: 5032679 (1991-07-01), Brandley et al.
Tyms et al., Cardin et al., J. Cell. Biochem. vol. SUPPL. pp. 365, 382 and 282 (1993).
A. W. Clowes et al., Nature, vol. 265, No. 5595, pp. 625-626 (1977).
A. L. Clowes et al., Journal of Vascular Surgery, vol. 10, No. 5, pp. 589-591 (1989).
E. J. Vandenberg et al., J. of Polymer Science, vol. 27, No. 11, pp. 3745-3757 (1989).
A. D. Cardin et al., Arteriosclerosis 9, pp. 21-32 (1989).
R. Montesano et al., Cell, vol. 42, 469-477 (1985).
R. M. Ottenbrite, ACS Symposium Series #186, pp. 205-220 (1982).
T. Kawasaki et al., J. Biochem 106, 401-405 (1989).
P. M. Rosoff et al., J. Med. Chem 263(36), 19535-19540 (1973).
R. Seiber et al., J. of Polymer Sci., Polymer Chem. Ed. 11(6), 1439-1442 (1973).
European Chem. News, p. 17 (Jul. 30, 1990).
C&E News, p. 11 (Jul. 16, 1990).
G. Odian, Principles of Polymerization, 2d, pp. 20-25 (1981).
R. K. Scopes, Protein Purification, pp. 186-198 (1987).
A. KoterA, Polymer Fractionation, pp. 43-65 (1967).
Polymer Fractionation, p. 462 (1967).
J. Chrom. Library, 41A, pp. A127-A208, A303-A399.
R. K. Scopes, Protein Purification, pp. 199-215 (1987).
DOWEX:ION Exchange, The Dow Chemical Co. 1958, pp. 39-66.
Macromolecules, vol. 1, Ch. 8 (1984).
Busch Steven J.
Cardin Alan D.
Mano Masayuki
Kulkosky Peter F.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Steve
Page Thurman K.
Svoboda Craig G.
LandOfFree
Antiproliferative oligomers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiproliferative oligomers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiproliferative oligomers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1884949